IOB - Delayed Quote USD

Bristol-Myers Squibb Company (0R1F.IL)

46.78

+0.05

+(0.11%)

At close: May 12 at 7:11:28 PM GMT+1

Drug wars: Wall Street says big questions remain about impact of Trump's new pricing order

Trump signed a new executive order Monday that would attempt to force drugmakers to lower pricing in the US compared to other developed nations.

Yahoo Finance 12 hours ago

BMY

CELG-RT

PFE
Drugmakers Avoid Worst-Case Pricing Scenario for Now

An executive order says if companies and the government don’t align on tying U.S. drug prices to other countries, the administration will impose its own plan.

The Wall Street Journal 6 hours ago

BMY

CELG-RT

NVS
Bristol-Myers Squibb, Sanofi Enter $700 Million Settlement With Hawaii in Plavix Lawsuit

Bristol-Myers Squibb (BMY) and three US-based units of Sanofi (SNY) have reached a settlement for $7

PREMIUM
MT Newswires 15 hours ago

SNY

CELG-RT
Trump’s Vow to Cut US Drug Prices Drags Pharma Stocks Lower

(Bloomberg) -- President Donald Trump said he plans to order a cut in US prescription drug costs to bring them in line with other countries, spurring a drop in pharmaceutical shares worldwide.Most Read from BloombergA New Central Park Amenity, Tailored to Its East Harlem NeighborsAs Trump Reshapes Housing Policy, Renters Face Rollback of RightsWhat’s Behind the Rise in Serious Injuries on New York City’s Streets?NYC Warns of 17% Drop in Foreign Tourists Due to Trump PoliciesLA Mayor Credits Trum

Bloomberg 17 hours ago

AZN

AZNCF

BERZ
BMY Q1 Earnings Call: Growth Portfolio Offsets Declines, Guidance Raised Amid Pipeline Advancements

Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) reported Q1 CY2025 results exceeding the market’s revenue expectations, but sales fell by 5.6% year on year to $11.2 billion. The company’s full-year revenue guidance of $46.3 billion at the midpoint came in 1.2% above analysts’ estimates. Its non-GAAP profit of $1.80 per share was 19.8% above analysts’ consensus estimates.

StockStory 19 hours ago

CELG-RT
Pharmaceutical Stocks Tumble on Trump Plan to Cut US Drug Prices

(Bloomberg) -- Shares of pharmaceutical companies fell across the world after US President Donald Trump said he planned to order a cut in US prescription drug costs to bring them in line with other countries, prompting concern that profits will take a hit.Most Read from BloombergA New Central Park Amenity, Tailored to Its East Harlem NeighborsAs Trump Reshapes Housing Policy, Renters Face Rollback of RightsWhat’s Behind the Rise in Serious Injuries on New York City’s Streets?Is Trump’s Plan to R

Bloomberg 20 hours ago

C

TAK

TKPHF
Bristol-Myers Squibb Company (BMY): One of the Best High-Yield Dividend Stocks for 2025 and Beyond

We recently published a list of the 15 Best High-Yield Dividend Stocks for 2025 and Beyond. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other best high-yield dividend stocks. Over the years, dividend-paying stocks have become increasingly popular as investors lean toward income-focused investment strategies. Many […]

Insider Monkey 2 days ago

CELG-RT
Drug companies to pay Hawaii $700 million to settle Plavix blood thinner lawsuit

Pharmaceutical companies have agreed to pay Hawaii $700 million to settle its lawsuit over the efficacy and safety of the blood thinner Plavix, the state attorney general's office announced Friday. A court ruling last year ordered Bristol Myers Squibb Company and three U.S.-based subsidiaries of French pharmaceutical company Sanofi to pay a combined $916 million. “Plavix has helped millions of people with cardiovascular disease around the world for nearly 30 years and it continues to be endorsed as a first-line therapy by leading treatment guidelines across the globe,” the statement added.

Associated Press Finance 3 days ago

SNY

CELG-RT
3 Healthcare Stocks in Hot Water

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the industry’s returns - over the past six months, healthcare stocks have collectively shed 13.3%. This drawdown was worse than the S&P 500’s 5.8% fall.

StockStory 4 days ago

DVA

WST

CELG-RT
A Look at Pharma ETFs After Strong Q1 Earnings

Many pharma bigwigs reported solid results, with some beating on earnings or revenues or both.

Zacks 4 days ago

JNJ

LLY

CELG-RT
Here's Why Bristol Myers Squibb (BMY) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks 4 days ago

CELG-RT
The Zacks Analyst Blog Highlights Verizon Communications, Bristol-Myers Squibb, Canadian Pacific and Nova LifeStyle

Verizon Communications, Bristol-Myers Squibb, Canadian Pacific and Nova LifeStyle are part of the Zacks top Analyst Blog.

Zacks 4 days ago

CP

CELG-RT

VZ
Top Research Reports for Verizon Communications, Bristol-Myers Squibb & Canadian Pacific

Today's Research Daily features new research reports on 16 major stocks, including Verizon Communications Inc. (VZ), Bristol-Myers Squibb Co. (BMY) and Canadian Pacific Kansas City Ltd. (CP), as well a micro-cap stock Nova LifeStyle, Inc. (NVFY).

Zacks 5 days ago

CP

CELG-RT

VZ
Improving Access to Care by Strengthening Local Health System Capacity

NORTHAMPTON, MA / ACCESS Newswire / May 7, 2025 / By Catharine Grimes, President of the Bristol Myers Squibb Foundation We are in an era of unprecedented medical innovation. Scientists are making remarkable progress to diagnose and treat diseases, ...

ACCESS Newswire 5 days ago

BMY

CELG-RT
Bristol-Myers Squibb (NYSE:BMY) Appoints Cari Gallman As New General Counsel

Bristol-Myers Squibb (NYSE:BMY) recently appointed Cari Gallman as the new Executive Vice President, General Counsel, and Chief Policy Officer following Sandra Leung’s retirement. This leadership change might have influenced investors' outlook on the company, contributing to a 3% increase in share price over the last week. However, this movement aligns with the overall market trend, which saw a rise of 2%. Moreover, broader market dynamics, including investor focus on impending Federal...

Simply Wall St. 6 days ago

BMY

CELG-RT
Bristol Myers Squibb announces $40bn US investment plan over five years

The funds will reportedly be allocated for R&D, technology advancements, and enhancing domestic manufacturing capacity.

Pharmaceutical Technology 6 days ago

CELG-RT

GLDAF
Bristol Myers Squibb Appoints Cari Gallman as Executive Vice President, General Counsel and Chief Policy Officer

PRINCETON, N.J., May 06, 2025--Bristol Myers Squibb Appoints Cari Gallman as Executive Vice President, General Counsel and Chief Policy Officer

Business Wire 6 days ago

BMY

CELG-RT
Elanco (ELAN) Reports Q1: Everything You Need To Know Ahead Of Earnings

Animal health company Elanco (NYSE:ELAN) will be reporting results tomorrow before market hours. Here’s what to look for.

StockStory 6 days ago

ELAN

CELG-RT
Bristol Myers to invest $40 billion in the US over 5 years

The announcement of new investment was first made by CEO Christopher Boerner in an opinion piece published in Stat News on Monday, and was later confirmed to Reuters by a company spokesperson. In the Op-Ed, Boerner said the money will be spread across research and development, technology and domestic manufacturing, as U.S. drugmakers prepare to deal with Trump's tariffs. Trump has repeatedly threatened tariffs on pharmaceutical imports on national security grounds.

Reuters 7 days ago

CELG-RT
Was Jim Cramer Right About Bristol-Myers Squibb Company (BMY)?

We recently published a list of Did Jim Cramer Hit or Miss On These 13 Stock Predictions? In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other stocks that Jim Cramer discussed during the episode of Mad Money on May 1st, 2024. During the Mad Money episode […]

Insider Monkey 7 days ago

CELG-RT

Performance Overview

Return	0R1F.IL	S&P 500 (^GSPC)
YTD	-14.52%	-0.64%
1-Year	+10.07%	+11.90%
3-Year	-30.83%	+48.70%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Bristol-Myers Squibb Company (0R1F.IL)

Drug wars: Wall Street says big questions remain about impact of Trump's new pricing order

Drugmakers Avoid Worst-Case Pricing Scenario for Now

Bristol-Myers Squibb, Sanofi Enter $700 Million Settlement With Hawaii in Plavix Lawsuit

Trump’s Vow to Cut US Drug Prices Drags Pharma Stocks Lower

BMY Q1 Earnings Call: Growth Portfolio Offsets Declines, Guidance Raised Amid Pipeline Advancements

Pharmaceutical Stocks Tumble on Trump Plan to Cut US Drug Prices

Bristol-Myers Squibb Company (BMY): One of the Best High-Yield Dividend Stocks for 2025 and Beyond

Drug companies to pay Hawaii $700 million to settle Plavix blood thinner lawsuit

3 Healthcare Stocks in Hot Water

A Look at Pharma ETFs After Strong Q1 Earnings

Here's Why Bristol Myers Squibb (BMY) is a Strong Value Stock

The Zacks Analyst Blog Highlights Verizon Communications, Bristol-Myers Squibb, Canadian Pacific and Nova LifeStyle

Top Research Reports for Verizon Communications, Bristol-Myers Squibb & Canadian Pacific

Improving Access to Care by Strengthening Local Health System Capacity

Bristol-Myers Squibb (NYSE:BMY) Appoints Cari Gallman As New General Counsel

Bristol Myers Squibb announces $40bn US investment plan over five years

Bristol Myers Squibb Appoints Cari Gallman as Executive Vice President, General Counsel and Chief Policy Officer

Elanco (ELAN) Reports Q1: Everything You Need To Know Ahead Of Earnings

Bristol Myers to invest $40 billion in the US over 5 years

Was Jim Cramer Right About Bristol-Myers Squibb Company (BMY)?

Performance Overview